Scholarlink

<p>The Type VI secretion system (T6SS) is widely recognized as a contractile nanomachine that mediates interbacterial antagonism, yet its biological roles and evolutionary logic vary substantially across bacterial lineages. In this Review, we synthesize recent advances in the <i>Acinetobacter</i> T6SS field and propose a unifying perspective in which the system functions as a context-dependent fitness module rather than a constitutive virulence weapon. We highlight how <i>Acinetobacter</i> has rewired a single T6SS platform through non-canonical structural solutions, multilayered regulatory integration, and an unusually expansive effector repertoire. Beyond microbial competition, emerging clinical and experimental evidence links T6SS activity to host immune amplification, disease severity, and the dynamics of horizontal gene transfer and antibiotic resistance. By integrating structural biology, regulatory logic, effector function, and clinical observations, this Review reframes the <i>Acinetobacter</i> T6SS as an adaptable system that balances aggression, persistence, and metabolic cost in polymicrobial and host-associated environments. This perspective not only advances conceptual understanding of T6SS diversity but also highlights translational opportunities for diagnostics, vaccines, and anti-virulence strategies targeting multidrug-resistant <i>Acinetobacter</i> infections.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The type VI secretion system of Acinetobacter: mechanisms, biology and therapeutic potential

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月27日

查看全文
  • Jing Jie,
  • Sanwei Gu,
  • Dan Li,
  • Meng Zhang,
  • Zhao-Qing Luo,
  • Lei Song

摘要

The Type VI secretion system (T6SS) is widely recognized as a contractile nanomachine that mediates interbacterial antagonism, yet its biological roles and evolutionary logic vary substantially across bacterial lineages. In this Review, we synthesize recent advances in the Acinetobacter T6SS field and propose a unifying perspective in which the system functions as a context-dependent fitness module rather than a constitutive virulence weapon. We highlight how Acinetobacter has rewired a single T6SS platform through non-canonical structural solutions, multilayered regulatory integration, and an unusually expansive effector repertoire. Beyond microbial competition, emerging clinical and experimental evidence links T6SS activity to host immune amplification, disease severity, and the dynamics of horizontal gene transfer and antibiotic resistance. By integrating structural biology, regulatory logic, effector function, and clinical observations, this Review reframes the Acinetobacter T6SS as an adaptable system that balances aggression, persistence, and metabolic cost in polymicrobial and host-associated environments. This perspective not only advances conceptual understanding of T6SS diversity but also highlights translational opportunities for diagnostics, vaccines, and anti-virulence strategies targeting multidrug-resistant Acinetobacter infections.